# Matchpoint Therapeutics Inc. — Form D

Matchpoint Therapeutics Inc. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2022-10-17. The offering totals $70.0M, of which $42.0M was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2022-10-17
- Form: D
- Accession: 0001950915-22-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $70.0M
- Amount sold: $42.0M
- Remaining: $28.0M
- Investors: 15
- Date of first sale: 2022-10-05
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-462017

## Issuer

- Name: Matchpoint Therapeutics Inc.
- CIK: 0001950915
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: ONE KENDALL SQUARE, CAMBRIDGE, MA, 02139
- Phone: 617-620-6280

## Officers, directors & promoters (5)

| Name | Role | Location |
| --- | --- | --- |
| Daniel Becker | Director | Cambridge, MA |
| Bruce Booth | Director | Cambridge, MA |
| Jason Hafler | Director | South San Francisco, CA |
| Andre Turenne | Director | Mountain View, CA |
| Andre Turenne | Executive Officer | Mountain View, CA |

## More

- [CIK 1950915 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1950915&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001950915-22-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.